運動トレーニングとビタミンD代謝 (Hybri-D)
過体重/肥満を有する成人におけるハイブリッド型高強度インターバルトレーニングのビタミンD代謝への影響
The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D [25(OH)D] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.
調査の概要
詳細な説明
Thirty adults with overweight/obesity (both males and females) who will meet the inclusion criteria will be randomly assigned to either an Exercise group (n=15) or a Control group (n=15). The Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet. The Control group will receive a balanced diet but will not participate in exercise training. Both groups will provide a resting blood sample and undergo assessment of their body composition (via bioelectrical impedance analysis), daily dietary intake (via dietary recalls) and physical activity level (via accelerometry) at baseline (prior to intervention), 6 weeks and 12 weeks.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Dimitrios Draganidis, PhD
- 電話番号:+302431047078
- メール:ddraganidis@uth.gr
研究連絡先のバックアップ
- 名前:Ioannis G Fatouros, PhD
- 電話番号:2431047047
- メール:ifatouros@uth.gr
研究場所
-
-
Karyes
-
Trikala、Karyes、ギリシャ、42100
- 募集
- Department of Physical Education and Sport Science, University of Thessaly
-
コンタクト:
- Ioannis G Fatouros, PhD
- 電話番号:2431047047
- メール:ifatouros@uth.gr
-
コンタクト:
- Athanasios Z Jamurtas, PhD
- 電話番号:2431047054
- メール:ajamurt@uth.gr
-
副調査官:
- Eytychia Giouvri, BSc
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- BMI = 25-35 kg/m2
- Absence of musculoskeletal injuries
- Absence of chronic health-related complications
- Non-smokers
Exclusion Criteria:
- Consumption of Vitamin D supplements
- Consumption of anti-inflammatory drugs, statins and/or steroids
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Exercise group
Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet |
Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period |
|
アクティブコンパレータ:Control group
Control group will receive a balanced diet but will not participate in exercise training |
Receive a balanced diet but abstain from any type of exercise training |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in 25-hydroxyvitamin D concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
25-OH-VD will be quantitatively determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in plasma Vitamin D binding protein concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
Vitamin D binding protein concentration will be determined in plasma |
At baseline, 6 weeks and 12 weeks
|
|
Change in calcium concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
Calcium concentration will be determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in albumin concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
Albumin concentration will be determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in aspartate aminotransferase (SGOT) concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
SGOT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
|
Change in alanine aminotransferase (SGPT) concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
SGPT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
|
Change in gamma-glutamyl transferase (γ-GT) concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
γ-GT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in reduced glutathione concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
Reduced glutathione concentration will be determined in blood erythrocytes |
At baseline, 6 weeks and 12 weeks
|
|
Change in oxidized glutathione concentration
時間枠:At baseline, 6 weeks and 12 weeks
|
Oxidized glutathione concentration will be determined in blood erythrocytes |
At baseline, 6 weeks and 12 weeks
|
|
Change in dietary intake
時間枠:At baseline, 6 weeks and 12 weeks
|
Dietary intake habits will be assessed through dietary recalls |
At baseline, 6 weeks and 12 weeks
|
|
Change in physical activity level
時間枠:At baseline, 6 weeks and 12 weeks
|
Physical activity will be assessed via accelerometry |
At baseline, 6 weeks and 12 weeks
|
|
Change in body composition
時間枠:At baseline, 6 weeks and 12 weeks
|
Body composistion will be assessed via bioelectrical impedance analysis (BIA) |
At baseline, 6 weeks and 12 weeks
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Dimitrios Draganidis, PhD、University of Thessaly
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- UTH_2612_8.10.2025
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。